|
ZNF557 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.004800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.901200E-01 |
| Normal-vs-Stage2 |
6.821200E-01 |
| Normal-vs-Stage3 |
2.781100E-03 |
| Normal-vs-Stage4 |
9.656500E-03 |
| Stage1-vs-Stage2 |
3.906000E-01 |
| Stage1-vs-Stage3 |
1.83720000002108E-06 |
| Stage1-vs-Stage4 |
1.389580E-04 |
| Stage2-vs-Stage3 |
7.263600E-02 |
| Stage2-vs-Stage4 |
1.093990E-01 |
| Stage3-vs-Stage4 |
8.305000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.653400E-01 |
| Normal-vs-AfricanAmerican |
2.899000E-01 |
| Normal-vs-Asian |
3.446400E-01 |
| Caucasian-vs-AfricanAmerican |
6.944400E-01 |
| Caucasian-vs-Asian |
1.521590E-01 |
| AfricanAmerican-vs-Asian |
1.806000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.905190E-01 |
| Normal-vs-Female |
6.898000E-01 |
| Male-vs-Female |
1.945630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.547400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.628000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.687500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.549560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.296000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.643400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.907800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.942400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.283980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.948200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.365520E-02 |
| Normal-vs-Grade 2 |
5.052000E-01 |
| Normal-vs-Grade 3 |
3.008200E-02 |
| Normal-vs-Grade 4 |
9.602400E-04 |
| Grade 1-vs-Grade 2 |
2.822000E-02 |
| Grade 1-vs-Grade 3 |
9.8790999999987E-05 |
| Grade 1-vs-Grade 4 |
1.22979999994666E-06 |
| Grade 2-vs-Grade 3 |
8.43580000000621E-05 |
| Grade 2-vs-Grade 4 |
4.19739999979463E-07 |
| Grade 3-vs-Grade 4 |
6.156100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.116400E-01 |
| Normal-vs-ccB subtype |
2.004000E-02 |
| ccA subtype-vs-ccB subtype |
3.91539999999857E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.061800E-01 |
| Normal-vs-N1 |
2.857600E-02 |
| N0-vs-N1 |
7.421500E-02 |
|
|
